Revised SPC: Humira (adalimumab) – all presentations

SPC has been updated with license extension for treatment of ulcerative colitis in patients from 6 years of age who have had an inadequate response to corticosteroids and/or 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications.

Source:

electronic Medicines compendium